EraCal Therapeutics: a new drug candidate for obesity

Elie Dolgin. Nature. 2020.

. 2020 Jun 30.

doi: 10.1038/d41586-020-01800-z. Online ahead of print.

No abstract available

Keywords: Diabetes; Drug discovery; Metabolism; Obesity.

Similar articles

Development of calorie restriction mimetics as therapeutics for obesity, diabetes, inflammatory and neurodegenerative diseases.
Chiba T, Tsuchiya T, Komatsu T, Mori R, Hayashi H, Shimokawa I. Chiba T, et al. Curr Genomics. 2010 Dec;11(8):562-7. doi: 10.2174/138920210793360934. Curr Genomics. 2010. PMID: 21629433 Free PMC article.
Obesity and diabetes gene discovery approaches.
Walder K, Segal D, Jowett J, Blangero J, Collier GR. Walder K, et al. Curr Pharm Des. 2003;9(17):1357-72. doi: 10.2174/1381612033454739. Curr Pharm Des. 2003. PMID: 12769728 Review.
THE PRACTICAL TREATMENT OF OBESITY.
YUDKIN J. YUDKIN J. Proc R Soc Med. 1965 Mar;58(3):200-1. doi: 10.1177/003591576505800328. Proc R Soc Med. 1965. PMID: 14269776 Free PMC article. No abstract available.
NITROGEN AND WEIGHT LOSSES DURING STARVATION AND REALIMENTATION IN OBESITY.
SWENDSEID ME, MULCARE DB, DRENICK EJ. SWENDSEID ME, et al. J Am Diet Assoc. 1965 Apr;46:276-9. J Am Diet Assoc. 1965. PMID: 14285450 No abstract available.
MicroRNAs: emerging roles in adipogenesis and obesity.
Peng Y, Yu S, Li H, Xiang H, Peng J, Jiang S. Peng Y, et al. Cell Signal. 2014 Sep;26(9):1888-96. doi: 10.1016/j.cellsig.2014.05.006. Epub 2014 May 15. Cell Signal. 2014. PMID: 24844591 Review.